Clinical Trial Update: Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the validation of 99mTc-EDDA-HYNIC-TOC diagnostic kits for neuroendocrine tumors (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Drugs mentioned

• 99mTc-EDDA-HYNIC-TOC Kits

Snippet

Sponsor: Latin American Cooperative Oncology Group | Conditions: Neuroendocrine Tumors | Phase 2 | Status: COMPLETED